IART logo

Integra LifeSciences Holdings Corporation (IART)

$13.55

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on IART

Market cap

$1.05B

EPS

0.16

P/E ratio

--

Price to sales

0.63

Dividend yield

--

Beta

1.28369

Price on IART

Previous close

$13.98

Today's open

$13.82

Day's range

$13.40 - $13.89

52 week range

$8.70 - $20.49

Profile about IART

CEO

Stuart Essig

Employees

4427

Headquarters

Princeton, NJ

Exchange

Nasdaq Global Select

Shares outstanding

77800976

Issue type

Common Stock

IART industries and sectors

Healthcare

Medical Equipment & Supplies

News on IART

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holding Corporation - IART

NEW YORK, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holding Corporation (“Integra” or the “Company”) (NASDAQ: IART). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

news source

GlobeNewsWire • 20 hours ago

news preview

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holding Corporation - IART

NEW YORK, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holding Corporation (“Integra” or the “Company”) (NASDAQ: IART).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

news source

GlobeNewsWire • Nov 10, 2026

news preview

Integra LifeSciences Holdings Corporation (IART) Presents at 2026 UBS Global Healthcare Conference Transcript

Integra LifeSciences Holdings Corporation (IART) Presents at 2026 UBS Global Healthcare Conference Transcript

news source

Seeking Alpha • Nov 10, 2026

news preview

Integra LifeSciences to Present at the 2026 UBS Global Healthcare Conference

PRINCETON, N.J., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Lea Knight, chief financial officer, will present at the 2026 UBS Global Healthcare Conference on Monday, November 9, 2026, at 2:45 p.m. ET.

news source

GlobeNewsWire • Nov 6, 2026

news preview

Integra LifeSciences to Highlight Hands-On Education and Neurosurgery Innovation at CNS 2026 Annual Meeting

PRINCETON, N.J., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in medical technology, today announced its participation in the 2026 Congress of Neurological Surgeons (CNS) Annual Meeting, taking place October 31-November 4 in Washington, D.C. At this year's meeting, Integra will showcase its comprehensive neurosurgery portfolio through interactive educational experiences, hands-on training and technologies that support neurosurgeons across the continuum of care.

news source

GlobeNewsWire • Oct 30, 2026

news preview

Did You Lose Money on Integra LifeSciences Holdings Corporation Stock? The Law Offices of Howard G.

BENSALEM, Pa.--(BUSINESS WIRE)--Investors who suffered losses on Integra LifeSciences Holdings Corporation ("Integra" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith today reported that it is conducting a securities fraud investigation on behalf of Integra LifeSciences Holdings Corporation (NASDAQ: IART) investors into whether the Company may have violated the federal securities laws. The investigation comes after a October 2, 2026 disclosure c.

news source

Business Wire • Oct 23, 2026

news preview

Lost Money on Integra LifeSciences Holdings Corporation Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 21.2% Share Price Drop

LOS ANGELES--(BUSINESS WIRE)--Investors who lost money on Integra LifeSciences Holdings Corporation ("Integra" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of Integra LifeSciences Holdings Corporation (NASDAQ: IART) investors into whether the Company may have violated the federal securities laws. The investigation follows the October 2, 2026 disclosure regarding Integra.

news source

Business Wire • Oct 23, 2026

news preview

Integra LifeSciences: Progress Remains Frustratingly Slow, But Valuation Is Getting Interesting

Integra LifeSciences remains pressured by operational challenges, but restructuring and a returning CEO offer renewed turnaround potential. IART's Wound Reconstruction business continues to underperform, though upcoming product relaunches and market normalization could drive recovery. Valuation appears undemanding, with EBITDA margin expected to exceed 20% in 2025 and double-digit FCF margins possible by 2028.

news source

Seeking Alpha • Oct 23, 2026

news preview

Lost Money on Integra LifeSciences Holdings Corporation Shares? The Law Offices of Frank R.

LOS ANGELES--(BUSINESS WIRE)--Integra LifeSciences Holdings Corporation ("Integra" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in Integra LifeSciences Holdings Corporation (NASDAQ: IART), examining whether the Company may have violated the federal securities laws. The investigation centers on the disclosure about Integra LifeScience.

news source

Business Wire • Oct 22, 2026

news preview

What Integra LifeSciences (IART) Said on Its Q3 Earnings Call

Integra LifeSciences NASDAQ: IART reported third-quarter revenue at the low end of its guidance range as a flooding-related disruption at its Cincinnati facility and slower-than-expected Tissue Reconstruction performance weighed on results. The company said strength in neurosurgery and international Specialty Surgery partially offset those pressures.

news source

MarketBeat • Oct 21, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Integra LifeSciences Holdings Corporation

Open an M1 investment account to buy and sell Integra LifeSciences Holdings Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in IART on M1